Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Prepaid Assets (2016 - 2025)

Fate Therapeutics (FATE) has disclosed Prepaid Assets for 14 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 55.59% year-over-year to $4.1 million, compared with a TTM value of $4.1 million through Dec 2025, down 55.59%, and an annual FY2025 reading of $4.1 million, down 55.59% over the prior year.
  • Prepaid Assets was $4.1 million for Q4 2025 at Fate Therapeutics, down from $5.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $27.4 million in Q4 2022 and bottomed at $4.1 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $11.2 million, with a median of $9.6 million recorded in 2024.
  • The sharpest move saw Prepaid Assets soared 210.07% in 2022, then tumbled 55.59% in 2025.
  • Year by year, Prepaid Assets stood at $8.8 million in 2021, then skyrocketed by 210.07% to $27.4 million in 2022, then crashed by 46.87% to $14.5 million in 2023, then tumbled by 36.02% to $9.3 million in 2024, then crashed by 55.59% to $4.1 million in 2025.
  • Business Quant data shows Prepaid Assets for FATE at $4.1 million in Q4 2025, $5.1 million in Q3 2025, and $6.2 million in Q2 2025.